期刊文献+

Hepsin基因对前列腺癌PC3细胞侵袭和增殖能力的影响 被引量:2

Effects of Hepsin gene on the biological behavior of prostate cancer PC3 cells
暂未订购
导出
摘要 目的:研究Hepsin基因对前列腺癌PC3细胞生物学特性的影响。方法:用脂质体介导的基因转染技术,将pHepsin-IRES2质粒转染前列腺癌PC3细胞,用G418(600mg/L)筛选出阳性克隆。实时PCR检测转染前后Hepsin表达;MTT法和BrdU法检测细胞生长曲线;Boyden小室和划痕法观察转染前后细胞侵袭力的变化。结果:建立稳定表达Hepsin基因的PC3细胞系;转染Hepsin基因的PC3细胞的生长速度和转染空载体的对照组没有显著差异;转染Hepsin基因后前列腺癌PC3细胞的侵袭力显著增加(P<0.05)。结论:Hepsin基因对前列腺癌PC3细胞的增殖无显著作用,可明显促进PC3细胞的侵袭力。 Objective:To investigate the effects of Hepsin gene on the biological behavior of prostate cancer PC3 cells. Methods:Plasmid pHepsin-IRES2 was transfeeted into prostate cancer PC3 cells by Fugen6, and cells that can express Hepsin stably was screened out by G418(600 mg/L). Hepsin mRNA levels were measured by Real-time PCR; Growth curve of the Hepsin gene transfected PC3 cells was drawn with the results of MTT and BrdU assay The Boyden chamber and wound healing were used to detect the difference of invasion and metastases between transfected and non-transfected cells. Results: Hepsin mRNA level in pHepsin-IRES2 transfected PC3 cells was significantly higher than that in control PC3 cells; The growth curve of the Hepsin gene transfected was cells by MTT and BrdU revealed that the Hepsin gene transfected PC3 cells had no significant effect in proliferation. As compared with control cells, the invasion ability of pHepsin-IRES2 transfected PC3 cells was increased obviously (P〈0.05). Conclusions: Hepsin, a type H transmembrane serine protease, has no impact on cell prolifera- tion, but promotes prostate cancer PC3 cells invasion and metastasis.
出处 《临床泌尿外科杂志》 2007年第11期861-863,共3页 Journal of Clinical Urology
关键词 前列腺癌 增殖 肿瘤侵袭 生物学 Prostate carcinoma Proliferation Metastasis Biology
  • 相关文献

参考文献7

  • 1刘斌 司徒镇强 吴军正 主编.细胞活力的检测方法[A].司徒镇强,吴军正,主编.细胞培养:第1版[C].西安:世界图书出版公司,2004.250-252.
  • 2吴珊,李玉林,王勇.肿瘤细胞浸润能力的体外实验研究及实际意义[J].白求恩医科大学学报,1995,21(3):249-251. 被引量:5
  • 3Dhanasekaran S M, Barrette T R, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer [J]. Nature, 2001,412,822-826.
  • 4Magee J A, Araki T, Patil S, et al. Expression profiling reveals hepsin overexpression in prostate cancer [J]. Cancer Res, 2001, 61, 5 692-5 696.
  • 5Kirchhofer D, Peek M, Lipari M T, et al. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2[J]. FEBSLett, 2005,579(9),1945-1950.
  • 6Humphrey P A, Zhu X, Zarnegar R,et al. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma[J]. Am J Pathol, 1995 ,147(2):386-396.
  • 7Wong A S, Pelech S L, Woo M M. Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis[J]? Oncogene, 2001 , 20(11), 1318-1328.

二级参考文献2

共引文献5

同被引文献22

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 2赵伟光,张建林,吴建国,朱应,李雁,朱忠超,刘志苏.HBx蛋白与Hepsin共表达可促进HBV复制[J].中国病毒学,2004,19(4):345-348. 被引量:1
  • 3甄永苏.治疗肿瘤的抗体靶向药物[J].中华肿瘤防治杂志,2006,13(22):1681-1682. 被引量:7
  • 4梁文立,周利群,辛殿琪,那彦群.差异表达基因Hepsin在前列腺癌中的表达及其意义[J].中国康复理论与实践,2006,12(12):1060-1062. 被引量:1
  • 5曹泽毅主编.中华妇产科学[M].第2版,北京:人民卫生出版社,2008:398-419.
  • 6Zou Z, Anisowicz A, Hendrix M J, et al. Maspin, a serpin with tumor -suppressing activity in human mammary epithelial cells [ J ]. Science, 1994,263:526 - 529.
  • 7Livat KJ , Schmittgen TD. Analysis of relative gene expression data using real- time quantitative PCR and the 2-~ct Method [J].Methods ,2001,25 (4) :402 - 428.
  • 8Tanimoto H Y, Yan Y, Clark J, et al. Hepsin, a cell surface serineprotease identified in epatoma cells, is overexpressed in ovarian cancer[ J]. Cancer Res, 1997, 57 (14) : 2884 - 2887.
  • 9Magee J A, Araki T, Patil S, et al. Expression profiling reveals hepsin overexpression in prostate cancer[ J]. Canncer Res, 2001, 61 ( 15 ) : 5692 - 5696.
  • 10Hooper J D, Clements J A, Quigley J P, et al. Type II transmembrane serine proteases insights into an emerging class of cell surface proteolytie enzymes[ J]. J Biol Chem, 2001,276(2) : 857 - 860.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部